COVAXIN
Bharat Biotech COVID-19 Vaccine Phase 3 Trials: AIIMS, Delhi Puts Up Advertisements Seeking Volunteers Amid Shortage of Participation in COVAXIN's Trials
COVID-19 Vaccine Covaxin Generate Antibodies That May Persist for 6-12 Months, Says Bharat Biotech
COVID-19 Vaccine Latest Update: Bharat Biotech Again Applies for Emergency Use Authorization for Covaxin
COVID-19 Vaccine Update: Covaxin to be Co-Developed by Bharat Biotech, Ocugen for US Market
Anil Vij Health Update: 'Haryana Minister is Undergoing Treatment at ICU Ward, All Vital Parameters Are Normal', Says Medical Superintendent of Medanta Hospital
Covaxin Phase 1 Test Results: Bharat Biotech COVID-19 Vaccine Candidate Triggers Immune Response, Shows No Serious Adverse Effect
COVID-19 Vaccine Latest Update: DCGI to Review Data of Covaxin, Covishield and BNT162b2 on December 9, Says Report
Covaxin: Phase 3 Human Trial for Bharat Biotech's COVID-19 Vaccine Starts at SRM Medical College Hospital and Research Centre in Chennai
Anil Vij, Diagnosed With COVID-19 After Taking 1st Dose of COVID-19 Vaccine Covaxin, Says 'Was Told Antibodies Build Up 14 Days After Second Shot'
Anti-Vaxxers Pose a Threat to COVID-19 Vaccine: Here's How Misinformation and Fake News Can Challenge Coronavirus Vaccine Rollout
Covaxin a 2-Dose Anti-Coronavirus Vaccine, Haryana Minister Anil Vij Got Only 1st Dose: Union Health Ministry
After Haryana Home Minister Anil Vij Tests COVID-19 Positive, Bharat Biotech Says COVAXIN Efficacy Can Be Determined Only 14 Days After Second Dose
Volunteer Anil Vij Tests Positive After Taking Trial Dose of COVID-19 Vaccine Covaxin; Here's Why It Is Not a 'FAILURE'
Bharat Biotech Says 'Anil Vij Didn't Receive Second Dose of COVID-19 Vaccine Covaxin, Efficacy Determined 14 Days Post 2nd Shot'
COVID-19 Vaccine: ‘Government Never Spoke Of Vaccinating Entire Country’ Says Rajesh Bhushan, Health Secretary
Google Trends